Cargando…
Influence of Escherichia coli chaperone DnaK on protein immunogenicity
The production of anti‐drug antibodies can impact significantly upon the safety and efficacy of biotherapeutics. It is known that various factors, including aggregation and the presence of process‐related impurities, can modify and augment the immunogenic potential of proteins. The purpose of the in...
Autores principales: | Ratanji, Kirsty D., Derrick, Jeremy P., Kimber, Ian, Thorpe, Robin, Wadhwa, Meenu, Dearman, Rebecca J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290234/ https://www.ncbi.nlm.nih.gov/pubmed/27859059 http://dx.doi.org/10.1111/imm.12689 |
Ejemplares similares
-
Editor’s Highlight: Subvisible Aggregates of Immunogenic Proteins Promote a Th1-Type Response
por: Ratanji, Kirsty D., et al.
Publicado: (2016) -
Immunogenicity of therapeutic proteins: Influence of aggregation
por: Ratanji, Kirsty D., et al.
Publicado: (2014) -
Structural Communication between the E. coli Chaperones DnaK and Hsp90
por: Grindle, Matthew P., et al.
Publicado: (2021) -
Role of Mycoplasma Chaperone DnaK in Cellular Transformation
por: Benedetti, Francesca, et al.
Publicado: (2020) -
The impact of thioredoxin reduction of allosteric disulfide bonds on the therapeutic potential of monoclonal antibodies
por: Gurjar, Shalom A., et al.
Publicado: (2019)